Bosisio Francesca, Jox Ralf J, Jones Laura, Rubli Truchard Eve
Geriatric palliative care, Lausanne University Hospital and University of Lausanne, Switzerland / Palliative and supportive care service, Lausanne University Hospital and University of Lausanne, Switzerland.
Geriatric palliative care, Lausanne University Hospital and University of Lausanne, Switzerland / Palliative and supportive care service, Lausanne University Hospital and University of Lausanne, Switzerland / Institute of Humanities in Medicine, Lausanne University Hospital and University of Lausanne.
Swiss Med Wkly. 2018 Dec 30;148:w14706. doi: 10.4414/smw.2018.14706. eCollection 2018 Dec 17.
Advance directives emerged in the 1960s with the goal of empowering people to exert control over their future medical decisions. However, it has become apparent, over recent years, that advance directives do not sufficiently capture the temporal and relational aspects of planning treatment and care. Advance care planning (ACP) has been suggested as a way to emphasise communication between the patient, their surrogate decision maker and healthcare professional(s) in order to anticipate healthcare decisions in the event that the patient loses decision-making capacity, either temporarily or permanently. In more and more countries, ACP has become common practice in planning the treatment of terminal diseases such as cancer or amyotrophic lateral sclerosis. However, even though neurodegenerative dementia results in the gradual loss of decision-making capacity, ACP is still extremely rare. There are several reasons for this. Firstly, some people have difficulties talking about illness and death, especially when this involves anticipation. Secondly, lay people and professionals alike struggle to consider Alzheimer’s disease and similar forms of dementia as terminal diseases. Thirdly, although patient decision-making capacity gradually decreases with the progression of dementia, the patient retains the ability to communicate and interact with surrogates and professionals until the later stages of the disease. Therefore, surrogates and professionals may feel unsure or even ambivalent when enforcing advance directives, in particular when those decisions may shorten a patient’s life expectancy. Finally, to be effective, existing ACP interventions should be adapted to patient’s cognitive impairments and lay out dementia-specific scenarios. Current WHO estimates indicate that by 2050 one out of four people will potentially have to take care of a relative with cognitive and communication impairments for several years. In Switzerland, the Federal Office of Public Health and the regional states have established national strategies on dementia and palliative care. These strategies emphasise the need for ACP as a means to prepare patients and their relatives for future decisions, as soon as someone is diagnosed with dementia. This moment is thus especially conducive to develop appropriate processes to prompt the elderly and people diagnosed with dementia to engage in ACP. Therefore, the aim of the present paper is to identify the benefits and challenges of ACP in dementia care, outline strategies to design appropriate procedures and tools, and provide professionals, patients and their relatives with opportunities to engage in ACP.
预立医疗指示于20世纪60年代出现,目的是使人们能够对自己未来的医疗决策施加控制。然而,近年来,很明显预立医疗指示并未充分涵盖规划治疗和护理的时间及关系方面。有人建议采用预先护理计划(ACP),以强调患者、其替代决策者和医疗保健专业人员之间的沟通,以便在患者暂时或永久丧失决策能力的情况下预先做出医疗决策。在越来越多的国家,ACP已成为规划癌症或肌萎缩侧索硬化等绝症治疗的常见做法。然而,尽管神经退行性痴呆会导致决策能力逐渐丧失,但ACP仍然极为罕见。原因有几个。首先,一些人在谈论疾病和死亡时存在困难,尤其是当这涉及到预先考虑时。其次,外行人以及专业人员都难以将阿尔茨海默病和类似形式的痴呆视为绝症。第三,尽管随着痴呆症的进展患者的决策能力会逐渐下降,但患者在疾病后期之前仍保留与替代者和专业人员沟通及互动的能力。因此,在执行预立医疗指示时,替代者和专业人员可能会感到不确定甚至矛盾,特别是当这些决策可能缩短患者预期寿命时。最后,为了有效,现有的ACP干预措施应适应患者的认知障碍,并列出针对痴呆症的具体情况。世界卫生组织目前的估计表明,到2050年,四分之一的人可能需要照顾患有认知和沟通障碍的亲属数年。在瑞士,联邦公共卫生局和各地区州已经制定了关于痴呆症和姑息治疗的国家战略。这些战略强调,一旦有人被诊断出患有痴呆症,就需要将ACP作为一种手段,帮助患者及其亲属为未来的决策做好准备。因此,这个时刻特别有利于制定适当的程序,促使老年人和被诊断患有痴呆症的人参与ACP。因此,本文的目的是确定ACP在痴呆症护理中的益处和挑战,概述设计适当程序和工具的策略,并为专业人员、患者及其亲属提供参与ACP的机会。